SQUAWK/NEWS
Account
Theme
Account
Menu
Live NewsCategoriesequity

FEVR (FEVR) News

Follow FEVR (FEVR) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 20 public stories across 3 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.

Symbol FEVR Asset equity Sector Markets 90 days 20 Last 21.21 Updated Sep 14, 2026, 06:00 AM UTC Open live news feed Open FEVR chart & news
L REG - Fevertree Drinks PLC - Director/PDMR Shareholding RNS Number: 4949U Fevertree Drinks PLC 14 September 2026 14 September 2026Fevertree Drinks plc("Fever-Tree" or the "Company")Notification and public disclosure of transactions by persons discharging managerial responsibi NEWS | Sep 14, 2026, 06:00 AM UTC L FEVR: U.S. and U.K. growth, diversification, and the Molson Coors partnership drive strong results Strong first-half growth was driven by U.S. and U.K. performance, diversification into non-tonic products, and market share gains. The Molson Coors partnership is accelerating U.S. growth, with local production and marke EQUITY | Sep 10, 2026, 11:12 AM UTC L FEVR: Robust growth across all regions, with U.S. momentum and diversification fueling future gains Strong H1 performance with 8% revenue growth, led by the U.S. and U.K. recovery, and expanding non-tonic portfolio. U.S. partnership with Molson Coors is driving distribution and marketing gains, with profitability set t EQUITY | Sep 10, 2026, 10:28 AM UTC L Fever-Tree's America Performance Boosted by Molson Coors Tie-Up — Market Talk Fever-Tree Drinks is showing good U.S. momentum following its tie-up with Molson Coors, Ed Mundy at Jefferies says. The U.K. maker of tonics and mixers reported an 11% organic increase in U.S. revenue over the first half EQUITY | Sep 10, 2026, 09:14 AM UTC L FEV R H1 FY26 brand revenue up 8% and adjusted EBITDA margin 10.9% H1 FY26 saw 8% brand revenue growth led by strong US and European performance and product diversification. Adjusted EBITDA margin improved to 10.9%, and cash generation supported a £60m share buyback. EARNINGS | Sep 10, 2026, 09:03 AM UTC L Fevertree interim adjusted revenue rises 8% to £183.6m In the six months to 30 June, Fevertree total adjusted brand revenue grew 8% to £183.6m. Adjusted EBITDA rose 9% to £20.1m, with US revenue up 7% to £66.9m. EARNINGS | Sep 10, 2026, 07:29 AM UTC L Fevertree declares interim dividend of 6.09p per share EQUITY | Sep 10, 2026, 06:35 AM UTC L Fevertree Drinks Says It Is Well Hedged With Regard to Glass and Aluminum Costs Fevertree Drinks Says It Is Well Hedged With Regard to Glass and Aluminum Costs COMMODITIES | Sep 10, 2026, 06:34 AM UTC L Fevertree Drinks Sees 2026 Performance in Line With Views Fevertree Drinks Sees 2026 Performance in Line With Views EQUITY | Sep 10, 2026, 06:33 AM UTC M Fevertree Drinks reports 1H pretax profit of GBP14.6M Fevertree Drinks reported 1H pretax profit of GBP14.6M, according to the feed. EQUITY | Sep 10, 2026, 06:33 AM UTC L Fevertree Drinks 1H operating profit GBP13.2M EARNINGS | Sep 10, 2026, 06:32 AM UTC L Fevertree reports 1H adjusted EBITDA of GBP20.1M EARNINGS | Sep 10, 2026, 06:32 AM UTC L Fevertree Drinks reports 1H revenue of GBP165.1M Fevertree Drinks reported 1H revenue of GBP165.1M. No other figures or comparisons were provided in the feed. EQUITY | Sep 10, 2026, 06:31 AM UTC L Fevertree Drinks Backs 2026 View Fevertree Drinks Backs 2026 View EQUITY | Sep 10, 2026, 06:23 AM UTC L Fevertree Drinks Says U.S. Momentum Building Under Molson Coors Partnership Fevertree Drinks Says U.S. Momentum Building Under Molson Coors Partnership EQUITY | Sep 10, 2026, 06:22 AM UTC L UK's Fevertree H1 revenue rises, backs 2026 outlook OverviewOutlookResult DriversCompany press release:Key DetailsAnalyst CoverageReuters Recommended ReadsFor questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feed EARNINGS | Sep 10, 2026, 06:14 AM UTC L Fever reports 7% revenue and 9% adjusted EBITDA growth Fever said revenue rose 7% year-over-year, with strong US and UK performance and portfolio diversification. Adjusted EBITDA increased 9%, and a £60m share buyback is underway. FY26 guidance is unchanged. EARNINGS | Sep 10, 2026, 06:13 AM UTC L Fevertree reports 7% revenue and 9% adjusted EBITDA growth Fevertree said revenue rose 7% year-on-year, with strong US and UK performance and portfolio diversification driving growth. Adjusted EBITDA increased 9%, supporting a £60m share buyback and higher dividend. EARNINGS | Sep 10, 2026, 06:03 AM UTC M Fevertree Drinks reports FY26 interim results to 30 June 2026 Fevertree Drinks plc said its FY26 interim results cover the period to 30 June 2026. The company reported strong brand revenue growth of 8% and ongoing strategic progress, including momentum under the Molson Coors partne EQUITY | Sep 10, 2026, 06:00 AM UTC L Fevertree Drinks files TR-1 on changes to voting rights breakdown Fevertree Drinks PLC filed a TR-1 notification for a standard form change in the breakdown of voting rights, with the reason stated as an event changing voting rights distribution. EQUITY | Sep 01, 2026, 02:28 PM UTC